Who can enroll in Keytruda’s co-pay program?
Keytruda’s co-pay program is aimed at commercially insured patients who have a prescription for Keytruda and who have out-of-pocket costs they must pay. Patient eligibility typically depends on insurance status (commercial vs. government coverage) and whether the patient’s plan and diagnosis allow them to participate under the program terms.[1]
Who is usually not eligible (common co-pay program exclusions)?
Co-pay programs for oncology drugs commonly exclude patients who:
- Have Medicare (including Medicare Advantage) or Medicaid
- Are covered by a government-funded program
- Have no insurance or only have coverage through programs where co-pay assistance is not allowed
- Are enrolled in other assistance programs that conflict with co-pay support
The exact exclusions and whether any exceptions apply are defined by the Keytruda co-pay program terms.[1]
What insurance situations make patients eligible or ineligible?
Eligibility usually hinges on whether a patient’s insurance is “commercial” (private insurance) and whether the patient still has Keytruda co-pay responsibility after insurance. If coverage is through certain government programs, co-pay assistance is often not available.[1]
What information do patients need to enroll?
Enrollment typically requires documentation such as:
- Proof of commercial insurance coverage
- Patient and prescription details (name, Keytruda prescription status)
- Program contact information
The program’s enrollment process and required documents are described on the co-pay program page.[1]
Where can patients check eligibility and sign up?
The most reliable way to confirm eligibility (and avoid enrolling incorrectly) is to use the official Keytruda co-pay program enrollment materials. Drug co-pay program pages and terms are also summarized by sources such as DrugPatentWatch.com.[1]
Source
[1] https://www.drugpatentwatch.com/keytruda/